BioInvent
Headquartered in Lund, Sweden, BioInvent is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy.
Last updated on
About BioInvent
Founded
1996Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$5MCategory
Sector
In Vitro and in Vivo Diagnostic SubstancesIndustry Group
DrugsIndustry
BiotechnologyLocation
City
LundState
SkaneCountry
SwedenBioInvent
Find your buyer within BioInvent
Tech Stack (18)
